Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. It offers clinical and genomics laboratory, inspection package, homecare diagnosis, SARS-COV-2 examination package, and examination panel services. It offers clinical and genomics laboratory, inspection package, homecare diagnosis, SARS-COV-2 examination package, and examination panel services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.. |
Info | Profile |
---|---|
Name | Diagnos Laboratorium Utama Tbk. |
Sector | Healthcare |
Industry | Healthcare Equipment & Providers |
Code | F1 |
Latest Quarterly | 12/31/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Bundamedik | 41.2 | 41.2 |
PT. Bunda Investama Indonesia | 38.8 | 38.8 |
Public < 5% | 20.0 | 20.0 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 80.0 | 80.0 |
Retail | 20.0 | 20.0 |
Individual | 0.0 | 0.0 |
Management | 0.0 | 0.0 |
Revenue Source | 2023 | 2022 |
---|---|---|
Doctor Referrals | 76.6% | 67.0% |
Corporate Clients | 14.4% | 25.4% |
Walk in Customers | 8.9% | 7.6% |
Others | 0.0% | 0.0% |
Revenue Region | 2023 | 2022 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Year | DPS | Yield [%] |
---|---|---|
2021 | 4.8 | 0.6 |
Stock | DGNS | DGNS |
Timeframe | Performance |
---|---|
1W % | 21.2 |
1Mo % | -5.9 |
3Mo % | -22.3 |
1Yr % | -49.7 |
Pivot | Points |
---|---|
R2 | 207 |
R1 | 173 |
S1 | 113 |
S2 | 87 |
Link download Laporan Keuangan emiten
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
DGNS | 280.70 | 178 B | 277 B | 163 B | 16 B | 1 B |
MIKA | 29.59 | 32.27 T | 32.11 T | 4,870 B | 1,820 B | 1,150 B |
SRAJ | -1,428.57 | 31.09 T | 34.06 T | 3,150 B | 509 B | -24 B |
SILO | 29.25 | 27.96 T | 31.32 T | 12,200 B | 2,450 B | 902 B |
HEAL | 29.31 | 15.14 T | 19.21 T | 6,720 B | 1,840 B | 536 B |
PRAY | 41.70 | 8.45 T | 9.49 T | 2,100 B | 482 B | 201 B |